Ligand Pharmaceuticals Inc. Revenue 2009–2025
Ligand Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ligand Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 51.7 M, a 14.09% increase year-over-year.
- Ligand Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 260.1 M, a 65.50% increase year-over-year.
- Ligand Pharmaceuticals Inc. annual revenue for 2025 was 268.1 M, a 60.40% increase from 2024.
- Ligand Pharmaceuticals Inc. annual revenue for 2024 was 167.1 M, a 27.28% increase from 2023.
- Ligand Pharmaceuticals Inc. annual revenue for 2023 was 131.3 M, a 33.09% decrease from 2022.
- Ligand Pharmaceuticals Inc. annual revenue for 2022 was 196.2 M.
Ligand Pharmaceuticals Inc. (LGND) — Frequently Asked Questions
Ligand Pharmaceuticals Inc. (LGND) is a publicly traded US company. It has a market capitalization of $5.03B. In fiscal 2025 it reported revenue of $268M and net income of $124M. Explore LGND's stock price, financial statements, earnings history, margins and key ratios below.
What is Ligand Pharmaceuticals Inc.'s market cap?
Ligand Pharmaceuticals Inc. (LGND) has a market capitalization of $5.03B.
What is the LGND stock price?
LGND trades at $247.85 (+1.88% on the day).
How much revenue does Ligand Pharmaceuticals Inc. make?
Ligand Pharmaceuticals Inc. reported revenue of $268M in fiscal 2025.
Is LGND profitable?
In fiscal 2025, Ligand Pharmaceuticals Inc. reported net income of $124M.